Corporate Social Responsibility

Gilead Sciences Corporate Social Responsibility

Videos from this campaign

Content from this campaign

Philanthropy & Cause Initiatives

Opinion: Why Corporate Philanthropy Must Stand Against Stigma
While as a company, we have unsurprisingly always taken a clear stance against stigma, Gilead has prioritized its grant-making to support organizations working at the community level in recent years.

Diversity & Inclusion

Gilead Launches Pharmaceutical Education Program to Increase Workplace Diversity (Black Enterprise)
Gilead has launched a first-of-its-kind educational partnership with historically Black colleges and universities (HBCUs) and Hispanic-Serving Institutions (HSIs).

Health & Healthcare

Understanding Hepatitis D: 4 Questions With Professor Maria Buti
Most people are familiar with the hepatitis B (HBV) and hepatitis C (HCV) viruses that attack the liver. But not many have heard of hepatitis D (HDV), the most severe form of viral hepatitis

Diversity & Inclusion

Charting a Career to Help Reduce Health Inequity: Porscha's Story
Dr. Porscha Showers’ route to health sciences wasn’t always a sure thing. Porscha, who grew up in Louisiana, wanted to become an attorney – despite having a mother who worked as a registered nurse and a father who was a laboratory chemist.

Health & Healthcare

Ending HIV-Related Stigma in the Southern United States: Gina's Story
Gina Brown has been living with HIV for 27 years and introduces herself as a social worker by training, but an activist by birth.

Diversity & Inclusion

Inside the Innovation: Pharmaceutical Development and Manufacturing Leaders Share Experiences
In the second installment of our “Inside the Innovation” series, Gilead’s Ken Kent and Monica Tijerina discuss our patient-focused approach to developing medicines and the importance of including diverse voices throughout the process.

Health & Healthcare

Gilead Policy Papers Show Pandemic's Impact on HIV Prevention and Care
Gilead HIV Policy Directors Dan Murphy and Pema McGuinness recently developed a series of policy papers that warn of the consequences if governments fail to take steps to prioritize and invest in HIV.

Diversity & Inclusion

Developing Future Social Justice Leaders at Tougaloo College
As the ninth of 13 children, Dr. Carmen J. Walters grew up in New Orleans, where her father built houses during the day and worked at the railroad at night, and her mother did a variety of jobs, such as cooking for local schools.

Health & Healthcare

Gilead's Rohini Mehtani, Ph.D. Reflects on The Importance of ASH21
Gilead’s Rohini Mehtani, Ph.D. reflects on the importance of ASH21.

Health & Healthcare

Russian Foundation Provides Career Guidance for Teens Living With HIV
Svetlana Izambaeva was 22 years old when she learned she had contracted HIV from her boyfriend in 2002. The news shocked her.
Gilead Sciences

More from Gilead Sciences

  1. Corporate Social Responsibility
    Gilead Sciences Corporate Social Responsibility
  2. Age Positively
    Those who experienced the early days of the HIV/AIDS epidemic remember the generation we lost and the enduring impact that has had on our community...
  3. Gilead 2015 CSR Report
    Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...